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Abstract
Background/Objectives: Sleep problems are commonly reported by persons with severe mental illness. Obstructive sleep 
apnoea syndrome (OSA) is commonly co-morbid with mental illness. Screening for OSA and its subsequent management 
may improve outcomes in this patient population. We screened for risk of  OSA among in-patients with severe mental illness 
to determine its prevalence as well as its correlates using a socio-demographic questionnaire and the Berlin questionnaire
Methods: A cross sectional descriptive exploratory survey of  in-patients (n=89) at a regional Neuro- Psychiatric hospital 
using a socio-demographic questionnaire and the Berlin questionnaire. 
Results: Eighteen patients (18/89; 20.9%) were classed as high risk for OSA. High risk for OSA was significantly associated 
with a higher body mass index; BMI (p<0.01), but not gender (p=0.53), diagnoses (p=0.84), co-morbidity (p=0.73) or use 
of  atypical antipsychotics (p=0.48).
Conclusion: Patients with severe mental illness are at high risk for OSA with being overweight higher BMI significantly 
associated with this high risk.
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Sleep disturbances are common complaints among in-
dividuals with mental illness1. These disturbances are 
associated with increased morbidity and mortality2-3. 
Obstructive sleep apnea syndrome (OSA) is a breath-
ing related sleep disorder associated with partial or 
complete upper airway obstruction and is a common 
co-morbidity in individuals with mental illness3.
The relationship between OSA and mental illness is 
complex. The clinical features of  OSA, like poor sleep 
quality, daytime fatigue or somnolence may overlap with 
symptoms of  certain mental illnesses4. Psychotropic 
drug-induced weight gain and a sedentary life style due 
to psychomotor retardation in individuals with mental 
illness may also increase the risk for the development 
of  OSA3.
In Western countries, the prevalence of  OSA is reported 
to be between 5% and 10%5-6 in the general population. 
Its prevalence is on average higher in the mentally ill2-3. 
In Nigeria, the prevalence of  OSA has been described 
in various targeted groups; heart failure patients4, and 
hypertensive patients7. However there is no study on 
the risk of  sleep apnea syndrome among the mentally ill 
who have an increased risk for the syndrome. This ex-
ploratory study aimed to determine the prevalence and 
correlates of  risk of  obstructive sleep apnea syndrome 
among in-patients at a regional neuropsychiatric hos-
pital in Nigeria. It is expected that the findings of  this 
report will increase the awareness of  psychiatrists con-
cerning this co-morbidity in sub-Saharan Africa, as well 
as argue for an intensive assessment of  sleep problems 
in mentally ill patients who do not respond to interven-




A cross-sectional study was carried out on the in-pa-
tients at the Federal Neuro- Psychiatric Hospital 
(FNPH), Benin-City, Nigeria over a 4 month period 
(July – October, 2013). The FNPH is a 220-bed hospital 
that offers both in- and out-patient psychiatric servic-
es. In-patient care is provided at the ‘acute’ and ‘stable’ 
wards in the hospital.
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Participants
Eighty-nine (89) in-patients out of  112 in-patients aged 
between 18 and 65 years were recruited for this study. 
These were patients who met the diagnostic criteria ac-
cording to ICD-10 for a psychiatric disorder. Patients 
who were admitted into the acutely ill wards were ex-
cluded from the study and only participants who were 
mentally stable and able to understand the nature and 
purpose of  the study were recruited. Patients in the 
drug treatment wards, general adult wards were thus 
surveyed. Due to age restrictions, we excluded patients 
in the child and adolescent wards
Measures
Socio-demographic and clinical characteristics of  each 
patient including age, gender, marital status, diagnosis, 
duration of  illness, history of  diabetes and hyperten-
sion and previous admissions,  were assessed using the 
socio-demographic questionnaire. 
Berlin questionnaire
Sleep apnea risk was determined using the Berlin Ques-
tionnaire8  which is a 10- item instrument designed to 
assess risk of  OSA in 3 categories of  questions relating 
to sleep apnea. Individuals with positive responses to 2 
or more categories were considered to have a high like-
lihood of  OSA and less than 2 positive or no responses 
were considered low risk. A score of  2 and above for 
each category was considered a positive response. 
Ethics
Ethical clearance was sought and obtained from the 
Ethics Committee of  the FNPH, Benin City. Each par-
ticipant was assessed by one of  the researchers and if  
found to be in a stable mental state and able to under-
stand the nature and purpose of  the study was recruited 
after filling the informed consent forms. Confidentiality 
and anonymity was assured and clients were told they 
could withdraw with no untoward consequence. Those 
found to be at high risk were offered referrals to a spe-
cialist for follow-up. 
Procedure
Written informed consent was obtained from each par-
ticipant after explanation of  the study protocol. The 
study instruments were administered to each partici-
pant by the researchers.
Each patient’s body weight in kilograms, height in me-
ters, neck circumference in centimetres and blood pres-
sure were measured and the interviews completed in 
English language.
Data analysis
Statistical analysis was done using the Statistical Package 
for the Social Sciences version 16 (SPSS 16.0). Descrip-
tive statistics was used to summarize the data. Compar-
isons between categorical and continuous variables and 
high risk for OSA were performed using the chi-square 
test and t-test respectively. Level of  significance was set 
at p < 0.05.
 
Results
Of  the eighty nine (89) in-patients recruited for this 
study, majority were males (n=62;69.7%). The age 
range of  the whole sample was between 18 and 63 
years with mean age of  35.39±10.57 years; the modal 
age group were those between 18 and 30 years (n=36; 
40.4%). Most were single (n=64; 71.9%), and Christian 
82 (92.1%).
Fifty five participants (63.2%) were being managed for 
schizophrenia, 31 (35.6%) for bipolar affective disor-
der and one (1.2%) for severe depression with psychot-
ic symptoms. The mean duration of  illness was 55.28 
(65.77) weeks. Thirty eight patients were receiving 
in-patient care for the first time. Fifteen (16.9%) had 
a physical co-morbidity which was hypertension, none 
had a history of  diabetes. Fifty four (62.1%) were on 
atypical antipsychotics, and 13 (14.9%) had co-morbid 
psychoactive substance use. Thirty four (38.2%) were 
overweight; with a BMI greater than 25. See Table 1. 
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Table 1: Socio-demographic and clinical characteristics of participants 
 
 



















































































Eighteen (20.7%) in-patients were classified as having 
high risk for OSA using the Berlin questionnaire. High 
risk for OSA was significantly associated with a higher 
average BMI (p<0.01), but not weight (p=0.06), diag-
nosis (p=0.84), gender (p=0.53), use of  atypical antip-
sychotics (p=0.48) or physical co-morbidity (p=0.73). 
See Table 2.
Compared to the group of  patients with normal range 
BMI, there was an increased risk of  OSA in the under-
weight (RR=1.5) and overweight (RR=2.8) groups. 
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Table 2: Comparison of continuous variables and risk for OSA 
 
Variable High risk OSA Low risk OSA t p 
Age (years) 
  
35.78 (9.53) 35.29 (10.89) 0.19 0.86 
Duration of illness (months) 62.76 (53.32) 47.90 (69.87) 0.53 0.52 
Height (metres) 1.70 (0.76) 1.73 (0.09) -1.08 0.23 
Weight (kg) 78.06 (16.05) 71.26 (12.86) 1.89 0.06 
BMI (kg/m2) 26.73 (5.27) 23.84 (3.66) 2.70 0.01 
 
Discussion 
We found that a fifth of  in-patients in this explora-
tory study were at high risk for OSA using the Berlin 
questionnaire. Though significant associations were 
not observed between high risk for OSA and most so-
cio-demographic and clinical variables, patients at high 
risk for OSA were on average overweight, older, using 
atypical antipsychotics and receiving inpatient care for 
schizophrenia.
The strength of  our findings is limited by its small 
sample size, the absence of  a reliable witness to cor-
roborate sleep habits and a bias for patients who are 
severely mentally ill. Furthermore, we only employed 
the use of  a screening instrument and each participant 
at high risk for OSA would require a diagnostic assess-
ment especially if  treatment may be initiated. The Ber-
lin Questionnaire has not been validated as well for use 
in psychiatric populations, in which illness symptoms 
and sedative effects of  medications may confound the 
sensitivity of  the screening instrument. A study deter-
mining its cut-off  for OSA risk is still required and lim-
its the strength of  our findings.  
The prevalence reported in this study is low when 
compared to similar studies in psychiatric popula-
tions. Weight appears to correlate strongly with OSA 
risk, thus a high rate of  54.1% observed in the study 
by Soreca and colleagues2 was among bipolar patients 
who were all overweight. In our sub sample of  over-
weight patients the risk for OSA was as high as 48%. 
Furthermore, we also observed that the risk of  OSA 
increased when compared to baseline (normal weight) 
in the underweight and overweight patient sub-groups. 
Compared to studies involving apparently healthy 
populations in Nigeria and employing the use of  the 
same screening instrument, we observed that risk for 
OSA was higher in our sample compared to apparently 
healthy persons10,11, but lower when compared to heart 
failure patients4. This finding is consistent with previ-
ous reviews that report a higher prevalence of  OSA 
in persons with mental illness compared to apparently 
healthy populations3.
Unlike in a previous report, we found an association be-
tween OSA risk and BMI9. Concerns about weight have 
been highlighted by clinicians in developing countries. 
With atypical antipsychotics becoming more affordable 
and little emphasis being placed on dietary regimens 
and exercise for the chronically mentally ill, it may be-
come evident that strategies to reduce weight or control 
its rise are cardinal to optimizing treatment outcomes. 
There is some evidence that use of  atypical antipsy-
chotics is associated with a greater severity of  OSA12.
 
Conclusion  
We report that there was a moderate risk for OSA 
among patients with severe mental illness. Body mass 
index (BMI) is strongly correlated with OSA risk and 
may be a modifiable risk factor for OSA.
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